QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
-14.79%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$75.3M
AUM Growth
+$75.3M
(-21%)
Cap. Flow
-$2.08M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Ventyx Biosciences
VTYX
|
$2.08M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $27.2M | 36.12% | 3,510,228 | – | – |
|
|
2
Ventyx Biosciences
VTYX
$171M
| $23.8M | 31.65% | 686,370 -60,000 | -8% | -$2.08M |
|
3
Tourmaline Bio
TRML
$601M
| $8.24M | 10.94% | 2,932,606 | – | – |
|
4
HilleVax
HLVX
$105M
| $7.52M | 9.98% | 558,923 | – | – |
|
5
Jasper Therapeutics
JSPR
$45.5M
| $5.96M | 7.92% | 8,519,648 | – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $1.57M | 2.09% | 2,370,142 | – | – |
|
7
Kezar Life Sciences
KZR
$28.9M
| $986K | 1.31% | 828,711 | – | – |
|